Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs

Aim. To assess the possibility of azilsartan medoxomil to achieve target blood pressure (BP) (less than 130/80 mm Hg), to study angioprotective features and reduction of adipokines levels and inflammatory markers in patients with hypertension and previous therapy with other ARBs.Material and methods...

Full description

Bibliographic Details
Main Authors: S. V. Nedogoda, E. V. Chumachek, V. V. Tsoma, A. S. Salasyuk, V. O. Smirnova, E. A. Popova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2019-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3097